[1]TannapfelA , BusseC , WeinansL , etal.INK4a-ARFalterationsandp53mutationsinhepatocellularcarcinomas[J].Oncogene, 2001, 20 (48) ∶7104-9.
|
[2]WeihrauchM , BenickeM , LehnertG , etal.FrequentK -ras-2muta tionsandp16 (INK4A) methylationinhepatocellularcarcinomasinwork ersexposedtovinylchloride[J].BrJCancer, 2001, 84 (7) ∶982-9.
|
[3]MatsudaY , IchidaT , MatsuzawaJ, etal.P16 (INK4) isinactivatedbyextensiveCPGmethylationinhumanhepatocellularcarcinoma[J].Gas troenterology, 1999, 116 (2) ∶394-400.
|
[4]SerranoM , HannonGJ , BeachD .Anewregulatorymotifincell-cyclecontrolcausingspecificinhibitionofcyclinD/CDK4[J].Nature, 1993, 366∶704-707.
|
[5]汤钊猷, 余业勤主编.原发性肝癌第二版[M].上海:上海科学技术出版社, 1999.498.
|
[6] FarandaA , CostaA , CanovaS , etal.ImageandflowcytometricanalysesofDNAcontentinhumansolidtumor.Acomparativestudy[J].AnalQuantCytolHistol, 1997, 19∶338-44.
|
[7]王鲁平, 虞积濯, 丁华野, 等.胃癌中生长抑素和DNA倍体的相关表达及其预后意义[J].临床与实验病理学杂志, 1998, 14∶23-25.
|
[1] | Ziyi LI, Wanjie ZHANG, Fuchun WANG, Xiaorong MAO, Junfeng LI. Role of T lymphocytes in primary sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2926-2931. doi: 10.3969/j.issn.1001-5256.2023.12.026 |
[2] | Long LIU, Ke SHI, Qun ZHANG, Chongping RAN, Jie HOU, Yi ZHANG, Xianbo WANG. Risk factors for hepatocellular carcinoma in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2021, 37(7): 1589-1593. doi: 10.3969/j.issn.1001-5256.2021.07.022 |
[3] | Yuecheng YU, Chengwei CHEN. Pathogenesis of drug-induced liver injury: Current understanding and future needs[J]. Journal of Clinical Hepatology, 2021, 37(11): 2515-2524. doi: 10.3969/j.issn.1001-5256.2021.11.003 |
[4] | Qu Yao, Zhang Wei. Role of cell apoptosis in the pathogenesis of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1397-1400. doi: 10.3969/j.issn.1001-5256.2019.06.049 |
[5] | Chang BinXia, Wang Hua, Zou ZhengSheng, Li BaoSen, Gao Bin. Pathogenesis and novel therapeutic targets of alcoholic liver disease[J]. Journal of Clinical Hepatology, 2014, 30(2): 113-117. doi: 10.3969/j.issn.1001-5256.2014.02.004 |
[6] | Liu HongHong, Fu JunLiang, Fu BaoYun, Zhang Zheng, Xu RuoNan, Luo ShengQiang, Shi Ming, Li YongGang, Wang FuSheng. The pathogenesis and risk factors related to prognosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(2): 153-155. |
[7] | Luo FangQiong, Pan Yu, Liu JingJing, Zhang Peng, Niu JunQi, Jiang YanFang. The Impact of Adefovior dipivoxil on Th1/Th2 cytokines in chronic hepatitis B Patients[J]. Journal of Clinical Hepatology, 2010, 26(1): 19-21. |
[8] | Huang ZhongFa, Zhu Qing, Fu QiMei, Bu QuanHui, Shi BinBin. The effect of Interferon treatment on cellular immuneresponses in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(5): 326-328. |
[9] | Zhao Shuang, Yan XueBing, Wang JinZhang, Hao JunGui, Wang MingShan, Feng Xia, Wan MeiRong. The study on imblance of cytotoxic T cells subtype (Tc1/Tc2) in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(6): 417-419. |
[17] | Yin HongZhu, Liu JinXing, Cao ZhiChen, Li BingShun, Tang HuiHua, Feng ZhongJun. The Study of the role of Soluble Intercellular Adhesion Molecule-1 in Patients with Chronic hepatitis B[J]. Journal of Clinical Hepatology, 2000, 16(4): 230-231. |